Skip to content
buyWeak

Junli He bought $4,480 of HRGN

CEO at Biostage, Inc.. 1,600 shares at an average of $2.80, traded Jun 21, 2024, filed Jul 2, 2024.

Conviction score
23
Value
$4,480
1,600 shares
Holdings after
254,600
+1% from before
From 52-week low
+20%
low $2.18, close $2.62
From 52-week high
-56%
high $6.00, as of Jun 21, 2024

Score components

  • Role
    CEO
    +25
  • Trade size
    $4k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.6%)
    -5
  • Price context
    56% below the 52-week high
    +8
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Median 6-month excess return -50% over 7 past buys
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -10.7%, 3m +89.3%, 6m +6.4%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

HRGNOct 12, 2026 · close 2.12
Since filing Jul 2, 2024: -24.3%SPY +45.4% · excess -69.7%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001493152-24-025927, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 21, 2024POpen-market purchase
Common Stock
+1,600$2.80$4,480254,600Jul 2, 2024

Related signals

Other insiders at Biostage, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
47Moderate
HRGNbuy
Biostage, Inc.
Junli He
CEO
$394k
368,630 shares
+38%
38Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$5,100
3,000 shares
+1%
33Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$594
300 shares
+0%
38Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$21k
11,225 shares
+4%
33Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$6,966
4,050 shares
+2%
20Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$6,598
2,299 shares
+1%
33Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$17k
5,101 shares
+2%
29Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$13k
2,700 shares
+1%
24Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$4,428
900 shares
+0%
19Weak
HRGNbuy
Biostage, Inc.
Junli He
CEO
$7,605
1,500 shares
+1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Junli He bought $4,480 of HRGN | InsiderTell